Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier

Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier

Brain tumors are one of the leading causes of cancer related death in both the adult and pediatric patient population. Gliomas represent a cohort of brain tumors derived from glial cell lineages which include astrocytomas, oligodendrogliomas and glioblastomas (GBMs). These tumors are known to grow a...

Full description

Bibliographic Details
Main Authors: Stephen C. Frederico, Corbin Darling, John P. Bielanin, Alexandra C. Dubinsky, Xiaoran Zhang, Constantinos G. Hadjipanayis, Gary Kohanbash
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
glioblastoma
GBM
immunotherapy
ICI
neoadjuvant
brain
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1057567/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1057567/full

Similar Items